Opioid Overdose Prevention and Treatment

May 12, 2019

Opioid management presents complex challenges, and early intervention is imperative to reduce risk and avoid dependence, addiction, or diversion.

Crisis Response Overview: Not all victims sustain physical injuries

February 19, 2019

Navigating the Landscape of Drug Formularies and Prescribing and Treatment Guidelines

November 4, 2018

Over the course of the next several years we can expect more and more jurisdictions to move towards adoption of legislative and/or regulatory measures as an effort to combat the nation’s opioid crisis and to control prescription utilization and cost. Our latest video covers tools such as closed formularies and opioid prescribing limits, along with prescribing oversight measures such as treatment guidelines.

The Growing Federal and State Challenges of Medical Marijuana

October 28, 2018

As of October 2018 a total of 29 states and the District of Columbia currently allow for medical marijuana and cannabis programs. What implications does this pose for workers’ compensation? Our latest video covers the current legislative and regulatory trends at the state and federal levels, along with the potential implications for the workers’ compensation industry.

When are Specialty Drugs, Biologics, and Biosimilars Used in Workers’ Compensation?

October 21, 2018

For workers’ compensation, specialty drugs are prescribed to treat conditions either directly or indirectly related to workplace injuries or illnesses. Directly related conditions, such as HIV and hepatitis, might occur when individuals are exposed to contaminated material (i.e. those working in healthcare or emergency service settings). Indirectly related conditions, such as inflammatory arthritis, are common, and the subsequent work disability and/or potential of being linked to this group of illnesses is significant. Other indirectly related conditions that could be compensable in workers’ compensation are those aggravated by a workplace injury, including multiple sclerosis. The impact specialty drugs will have on workers’ compensation claims will depend largely on the demographics of the insured population.